LU91297I2 - Vaccin rotavirus (vivant,solution buvable) et ses dérivés pharmaceutiquement acceptable (rotateq) - Google Patents
Vaccin rotavirus (vivant,solution buvable) et ses dérivés pharmaceutiquement acceptable (rotateq)Info
- Publication number
- LU91297I2 LU91297I2 LU91297C LU91297C LU91297I2 LU 91297 I2 LU91297 I2 LU 91297I2 LU 91297 C LU91297 C LU 91297C LU 91297 C LU91297 C LU 91297C LU 91297 I2 LU91297 I2 LU 91297I2
- Authority
- LU
- Luxembourg
- Prior art keywords
- rotateq
- live
- pharmaceutically acceptable
- acceptable derivatives
- oral solution
- Prior art date
Links
- 229940124878 RotaTeq Drugs 0.000 title 1
- 229940124859 Rotavirus vaccine Drugs 0.000 title 1
- 229940100688 oral solution Drugs 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 238000006386 neutralization reaction Methods 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 241000702673 Bovine rotavirus Species 0.000 abstract 1
- 241000617996 Human rotavirus Species 0.000 abstract 1
- 241000702670 Rotavirus Species 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12647787A | 1987-11-30 | 1987-11-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
LU91297I2 true LU91297I2 (fr) | 2007-02-20 |
Family
ID=22425038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU91297C LU91297I2 (fr) | 1987-11-30 | 2006-12-20 | Vaccin rotavirus (vivant,solution buvable) et ses dérivés pharmaceutiquement acceptable (rotateq) |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0323708B1 (fr) |
JP (1) | JP2818760B2 (fr) |
AT (1) | ATE128873T1 (fr) |
AU (1) | AU618973B2 (fr) |
CA (1) | CA1303525C (fr) |
DE (2) | DE122006000071I1 (fr) |
ES (1) | ES2079358T3 (fr) |
GR (1) | GR3018262T3 (fr) |
IL (1) | IL88534A (fr) |
LU (1) | LU91297I2 (fr) |
NL (1) | NL300252I2 (fr) |
ZA (1) | ZA888931B (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU618963B2 (en) * | 1987-08-07 | 1992-01-16 | Institut Pasteur | Vaccines whose characteristic epitope is incorporated into a protein of picornavirus, in particular, poliovirus |
US5626851A (en) * | 1987-11-30 | 1997-05-06 | The Wistar Institute Of Anatomy And Biology | Rotavirus reassortant vaccine |
WO1992001784A1 (fr) * | 1990-07-26 | 1992-02-06 | The Wistar Institute Of Anatomy & Biology | Vaccin produit par reassortiment de rotavirus |
US5610049A (en) * | 1991-05-01 | 1997-03-11 | The Wistar Institute Of Anatomy And Biology | Human rotavirus HCR3A and method of growing said rotavirus |
US5900238A (en) * | 1995-07-27 | 1999-05-04 | Immunex Corporation | Vaccine delivery system |
ID20581A (id) * | 1996-10-18 | 1999-01-21 | Res Fnd For Micbial Diseases O | Antigen rotavirus, vaksin dan agen diagnostik untuk infeksi rotavirus, serta metode untuk menghasilkan antigen |
CN110903403B (zh) * | 2019-12-16 | 2021-07-13 | 中国农业大学 | 一种牛轮状病毒嵌合抗原以及检测牛轮状病毒抗体的胶体金免疫层析试纸卡 |
KR102374547B1 (ko) * | 2021-05-31 | 2022-03-14 | 에스케이바이오사이언스(주) | 재배열 로타바이러스의 제조 방법 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4571385A (en) * | 1983-06-27 | 1986-02-18 | The United States Of America As Represented By The Department Of Health And Human Services | Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors |
US4636385A (en) * | 1985-02-15 | 1987-01-13 | The Wistar Institute Of Anatomy & Biology | Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection |
-
1988
- 1988-11-28 AU AU26306/88A patent/AU618973B2/en not_active Expired
- 1988-11-29 IL IL8853488A patent/IL88534A/en active Protection Beyond IP Right Term
- 1988-11-29 CA CA000584371A patent/CA1303525C/fr not_active Expired - Lifetime
- 1988-11-29 ZA ZA888931A patent/ZA888931B/xx unknown
- 1988-11-30 JP JP63301117A patent/JP2818760B2/ja not_active Expired - Lifetime
- 1988-11-30 DE DE19883854575 patent/DE122006000071I1/de active Pending
- 1988-11-30 AT AT88311331T patent/ATE128873T1/de active
- 1988-11-30 ES ES88311331T patent/ES2079358T3/es not_active Expired - Lifetime
- 1988-11-30 DE DE3854575T patent/DE3854575T2/de not_active Expired - Lifetime
- 1988-11-30 EP EP88311331A patent/EP0323708B1/fr not_active Expired - Lifetime
-
1995
- 1995-11-30 GR GR950403377T patent/GR3018262T3/el unknown
-
2006
- 2006-12-14 NL NL300252C patent/NL300252I2/nl unknown
- 2006-12-20 LU LU91297C patent/LU91297I2/fr unknown
Also Published As
Publication number | Publication date |
---|---|
ES2079358T3 (es) | 1996-01-16 |
IL88534A (en) | 1994-02-27 |
EP0323708B1 (fr) | 1995-10-11 |
IL88534A0 (en) | 1993-12-08 |
GR3018262T3 (en) | 1996-02-29 |
DE3854575T2 (de) | 1996-05-15 |
EP0323708A1 (fr) | 1989-07-12 |
AU2630688A (en) | 1989-06-01 |
JP2818760B2 (ja) | 1998-10-30 |
JPH02138970A (ja) | 1990-05-28 |
DE3854575D1 (de) | 1995-11-16 |
AU618973B2 (en) | 1992-01-16 |
CA1303525C (fr) | 1992-06-16 |
ATE128873T1 (de) | 1995-10-15 |
ZA888931B (en) | 1989-07-26 |
DE122006000071I1 (de) | 2007-04-05 |
NL300252I1 (nl) | 2007-01-01 |
NL300252I2 (nl) | 2007-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU91297I2 (fr) | Vaccin rotavirus (vivant,solution buvable) et ses dérivés pharmaceutiquement acceptable (rotateq) | |
NO20015073D0 (no) | Vaksiner | |
AR004335A1 (es) | Formulaciones farmaceuticas | |
FI892131A0 (fi) | Analoger till underenheter av bordetellatoxin, vilka haerstammar fraon hybrid-dna. | |
WO2003003941A3 (fr) | Vaccin monodose a base de mycoplasma hyopneumoniae | |
EP0192404A3 (fr) | Vaccin, méthode de préparation et son utilisation pour la vaccination d'humains contre une infection à rotavirus | |
Stephen et al. | Swine influenza virus vaccine: potentiation of antibody responses in rhesus monkeys | |
Zapikian et al. | Alternative approaches to the development of a rotavirus vaccine. | |
DK0493575T3 (da) | Vaccine af reassortant rotavirus | |
DE69629812D1 (de) | Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4 | |
DK0626008T3 (da) | Vaccine, der som en adjuvans indeholder acemannan | |
KR890701087A (ko) | 부스피론 및 그의 염의 경구 투여용 제제 | |
EP1237573B1 (fr) | Utilisation de proteines immunogenes immunosuppressives ou angiogeniques rendues inactives pour la production d'lga secretoires | |
Levine et al. | Future vaccines against enteric pathogens | |
Cohen et al. | Two injections of diphtheria-tetanus-pertussis-polio vaccine as the backbone of a simplified immunization schedule in developing countries | |
Lanata et al. | Safety, immunogenicity and efficacy of one or three doses of the rhesus tetravalent rotavirus vaccine in Lima, Peru | |
ATE462446T1 (de) | Immunogenischen zusammensetzung von lebendigen rotaviren mit verringertem risiko von nebenwirkungen | |
FR2796282B1 (fr) | Vaccin inactive contre la calicivirose feline | |
IT1233419B (it) | Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria | |
MD1855G2 (ro) | Metodă de imunizare a păsărilor împotriva infecţiilor virale (variante) | |
IT1226728B (it) | Coniugato peptidico immunologicamente attivo utile come vaccino antimalaria e metodo di immunizzazione impiegante lo stesso | |
Dodin et al. | Shaba-Zaire choleric epidemy, 1983: Field-trial data on the activity of Institut Pasteur anticholeric oral vaccine. | |
Flewett | Rotaviruses: expectations for a vaccine | |
Ijaz et al. | Potentials of synthetic peptides as rotavirus vaccine and therapy | |
Vesikari | Rotavirus vaccines for prevention of acute gastroenteritis in young infants |